Clinical Trial Update: Bone, Exercise, Alendronate, and Caloric Restriction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate the effects of alendronate combined with exercise and caloric restriction on bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bone Loss | Phase 4 | Status: RECRUITING